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 Vaccination is one of control strategies 
implemented in endemic countries such as Egypt 
and Indonesia [1,2]. Most commercial AI vaccines 
available in Indonesia are adjuvanted inactivated 
AI vaccines applied through intramuscular routes. 
Vaccine application by subcutaneous or 
intramuscular injection can cause pain and stress 
in poultry, the route of vaccine through the nasal 
drip (intranasal) is a more convenient and painless.  
 However, respiratory applied inactivated 
influenza is poorly immunogenic. Therefore prior 
to developing inactivated intranasal vaccine, it is 
necessary to study  antibody response to 
inactivated AI virus which exposed through 
intranasal route. The aim of our research was to 
determined antibody response of ducks and 
chickens against avian influenza virus (AIV) 
subtype H5N1 after intranasally immunization. 
 
MATERIALS AND METHODS  
 A total of 22 AIV antibody negative ducks 
and 50 specified pathogen free (SPF) chickens 
were used in this research. Each animal groups 
were divided into two groups: control group and 
immunization group. Birds in control group were 
inoculated using 0,1 ml presterilized phospate 
buffer saline (PBS) , whilst the other groups were 
inoculated using 0,1 ml inactived AIV subtype 
H5N1 clade 2.3.2 (A/Ck/SR1/15)  containing 128 
hemaglutinin unit (HAU)/25µl intranasally.  Serum 
samples were collected at day 1, 4, 7 and 10 post 
inoculation. Antibody against AIV were determined 
using Enzyme Linked Immunosorbent Assay 
(ELISA) technique. 
 
RESULT AND DISCUSSION 
 Our results showed that 3 of 13 (23%) 
ducks inoculated with inactivated AI virus had 
specific antibodies to AI, while others did not form 
specific antibodies against AI. Two of the three 
ducks with specific antibodies were positive only 
on day 1 after inoculation, and only one duck had 
positive AI antibodies on day 1.4,7, and 10 after 
inoculation. Whilst, in chickens, only 2 of 25 (8%) 
chickens inoculated with inactivated AI virus had 
antibodies specific to AI, antibodies detected on 
day 4 after inoculation. All birds among control 
group were not develop apecific antibody against 
AIV.  
 Our result were in accordance  to earlier 
study by De Geus et al. [3] showed that adjuvanted 
inactivated AI H9N2 with chitosan or aluminum OH 
applied through intranasal route were not able to 
induce spesific antibody formation. However other 
study  by Worall et al. [4] were in contrary with our 
result, their study showed that inactivated AI H5N1 
vaccine with chitosan and sialidase applied 
through intanasal route were able to stimulated 
the formation of IgA specific to AI. In this study, we 
only evaluated the presence of antibodies in serum 
IgG, and did not evaluate the presence of specific 
IgA from the mucosa. Provision of antigens via 
intranasal route should stimulate local immune 
formation better.  
 
CONCLUSION 
 Lack of antibody formation might be due 
to low concentration of virus or most likely due to 
absence of adjuvantia, showing the need of 
improving immunogenecity of inactived AIV if we 
want to develop intranasally vaccine. 
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